DarioHealth Adds Healthcare Veteran to Board to Drive Commercial Scaling
Event summary
- DarioHealth appointed John R. Palumbo to its Board of Directors on April 13, 2026.
- Palumbo brings over 40 years of healthcare experience, including senior roles at AmerisourceBergen and Allscripts.
- His expertise is expected to accelerate Dario's commercial partnerships and scaling efforts.
- Palumbo currently serves on multiple digital health company boards, including Lucid Diagnostics and Qless.
The big picture
DarioHealth's appointment of John R. Palumbo reflects its strategic shift towards commercial scaling through partnerships. Palumbo's extensive experience in healthcare operations and digital health positions Dario to navigate the consolidating care delivery ecosystem. His relationships with key decision-makers across payers, providers, and health services organizations are expected to drive significant commercial momentum for the company's multi-chronic condition digital therapeutics platform.
What we're watching
- Commercial Scaling
- How Palumbo's industry relationships will accelerate Dario's partner-led go-to-market strategy.
- Strategic Value
- Whether Dario can capture its full strategic value through these commercial channels.
- Operational Efficiency
- The pace at which Dario transitions to a more capital-efficient model under Palumbo's guidance.